SCHEMBL3073023

SCHEMBL3073023

N=C(S)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL11260026 0.97 F2 (0.50)
Bromide SCHEMBL8216160 0.97 F2 (0.50)
SCHEMBL15219042 0.75 F2 (0.52)
SCHEMBL2883723 0.73 CA2 (0.58)
SCHEMBL2883726 0.73 CA2 (0.58)
Benzamide SCHEMBL30081945 0.73
SCHEMBL16814995 0.73 F2 (0.58)
SCHEMBL6429964 0.73 CA2 (0.58)
SCHEMBL17504065 0.73 CA2 (0.58)
SCHEMBL3805878 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303546-A1 Process And Intermediates For The Preparation Of Pyroxasulfone ADAMA AGAN LTD. (IL) 2023-09-28 US claimed
EP-0005385-B1 PIPERAZINE METHANE IMINE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL USE LAROCHE NAVARRON S.A. Société dite: (FR) 1982-09-01 EP claimed
EP-0005385-A1 Piperazine methane imine derivatives, methods for their preparation and their therapeutical use LAROCHE NAVARRON S.A. Société dite: (FR) 1979-11-14 EP claimed
US-12582619-B2 Compounds, compositions, and methods for treating or ameliorating, or preventing viral infections THOMAS JEFFERSON UNIVERSITY (US) 2026-03-24 US disclosed
EP-4673138-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 EP disclosed
US-20240307325-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS UNIV JEFFERSON (US) 2024-09-19 US disclosed
WO-2024182739-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 WO disclosed
EP-4277898-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS Thomas Jefferson University (US) 2023-11-22 EP disclosed
WO-2023200315-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME 주식회사 엘지화학 2023-10-19 WO disclosed
CN-110386919-B Nuclear transport modulators and uses thereof 卡尔约药物治疗公司 2023-07-14 CN disclosed
CN-110183422-B Nuclear transport modulators and uses thereof 卡尔约药物治疗公司 2023-07-14 CN disclosed
US-6093733-A FOR THE TREATMENT OR PREVENTION OF DISEASES THE TREATMENT OR PREVENTION OF WHICH IS MEDIATED BY MUSCARINIC RECEPTOR AGONISM; ALZHEIMER'S DISEASE PFIZER INC. 2000-07-25 US disclosed
EP-0805153-A1 Novel muscarinic receptor agonists PFIZER INC. (US) 1997-11-05 EP disclosed
EP-0005385-B1 PIPERAZINE METHANE IMINE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL USE LAROCHE NAVARRON S.A. Société dite: (FR) 1982-09-01 EP disclosed
US-4335043-A Substituted N-methylene derivatives of thienamycin MERCK & CO., INC. (US) 1982-06-15 US disclosed
US-4259334-A Piperazines and therapeutic utility LAROCHE NAVARRON S.A. (FR) 1981-03-31 US disclosed
US-4232030-A ANTIBIOTICS MERCK & CO., INC. (US) 1980-11-04 US disclosed
US-4194047-A Substituted N-methylene derivatives of thienamycin MERCK & CO., INC. (US) 1980-03-18 US disclosed
EP-0005385-A1 Piperazine methane imine derivatives, methods for their preparation and their therapeutical use LAROCHE NAVARRON S.A. Société dite: (FR) 1979-11-14 EP disclosed
EP-0001264-A1 Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation MERCK & CO. INC. (US) 1979-04-04 EP disclosed